At Biogen, we believe that having a diverse and inclusive workplace allows us to empower our workforce, foster innovation and achieve better business results. We are committed to bringing in a rich mix of talent into our organization, of all backgrounds and experiences, so that our employees reflect the communities we serve.
With full support from our Executive Committee, we have developed an industry-leading D+I strategy, focusing on Inclusive Talent Systems, Health Equity and Everyone Owning D+I. Our strategy promotes the ownership of this important work and advances the company’s leadership in neuroscience.
Additionally, through programs such as our Black and Latinx Executive Roundtable, and the BioDiversity Fellows Program, which Biogen co-created with The Partnership, we aim to provide our employees with opportunities for growth and development throughout their career.
Through cutting-edge science and medicine, Biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases.
Founded in 1978, Biogen is a pioneer in biotechnology, and today, the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis.